Diphtheria Pipeline Products and Comparative Analysis with Company Profiles Research Report Available at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds 'Diphtheria - Pipeline Review, H1 2015', provides an overview of the Diphtheria's therapeutic pipeline.

Diphtheria Pipeline Review H1 2015

Diphtheria Pipeline Review H1 2015

The report “Neutropenia - Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Neutropenia. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Complete report with TOC is available at http://www.rnrmarketresearch.com/diphtheria-pipeline-review-h1-2015-market-report.html .

The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies discussed in this report are:-

  • Beijing Minhai Biotechnology Co., Ltd
  • Biological E. Limited
  • Daiichi Sankyo Company, Limited
  • GlaxoSmithKline Plc
  • Green Cross Corporation
  • Indian Immunologicals Limited
  • LG Life Sciences, Ltd.
  • Panacea Biotec Limited
  • Prometheon Pharma, LLC
  • Sanofi
  • Sanofi Pasteur SA
  • Serum Institute of India Limited
  • Sinovac Biotech Ltd.
  • Zydus Cadila Healthcare Limited

Order a purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=395210 . (This is a premium report priced at US$2000 for a single user License.)

Drug profiles mentioned in this reports are:-

  • (diphtheria + tetanus + pertussis) vaccine
  • diphtheria + pertussis (acellular) + tetanus vaccine
  • diphtheria + pertussis + tetanus + hepatitis B + haemophilus influenza [serotype B] vaccine
  • diphtheria + pertussis + tetanus vaccine
  • diphtheria + tetanus + pertussis (acellular) + haemophilus influenza [serotype B] + polio [sabin] vaccine
  • diphtheria + tetanus + pertussis (acellular) vaccine
  • diphtheria + tetanus + pertussis (whole cell) + haemophilus influenzae [serotype B] + polio (pentavalent) vaccine
  • diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [serotype B] + polio (hexavalent) vaccine
  • diphtheria + tetanus + pertussis (whole-cell) + haemophilus influenzae [serotype B] vaccine
  • diphtheria + tetanus + pertussis (whole-cell) + hepatitis B + haemophilus influenzae [serotype B] (pentavalent) vaccine
  • diphtheria + tetanus + pertussis (whole-cell) + hepatitis B + haemophilus influenzae [serotype B] vaccine
  • diphtheria + tetanus + pertussis (whole-cell) + poliomyelitis + haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] (7-valent) vaccine
  • diphtheria + tetanus + pertussis (whole-cell) vaccine
  • diphtheria + tetanus vaccine
  • diphtheria + tetanus+ pertussis (whole cell) vaccine
  • diphtheria + tetanus+ pertussis (wholecell) + hepatitis [Type B] + haemophilus influenzae [type B] (pentavalent) vaccin
  • diphtheria + tetanus+ pertussis (wholecell) + hepatitis [Type B] + poliomyelitis + haemophilus influenzae [type B] (hexavalent) vaccine
  • diphtheria vaccine
  • GC-1107
  • GC-3111A
  • PR-5I
  • VN-0103

Scope of this report:

The report provides a snapshot of the global therapeutic landscape of Diphtheria. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities. The report reviews key players involved in the therapeutics development for Diphtheria and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects. A review of the Diphtheria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage is based on various stages of development ranging from pre-registration till discovery and undisclosed stages.

Table of Contents:-

  • List of Tables
  • List of Figures
  • Diphtheria Overview
  • Therapeutics Development
  • Pipeline Products for Diphtheria - Comparative Analysis
  • Diphtheria - Therapeutics under Development by Companies
  • Diphtheria - Therapeutics under Investigation by Universities/Institutes
  • Diphtheria - Pipeline Products Glance
  • Late Stage Products
  • Clinical Stage Products
  • Early Stage Products
  • Drug Profiles
  • Featured News & Press Releases

Ritesh Tiwari
TX, Dallas North - Dominion Plaza
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales(at)rnrmarketresearch(dot)com

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on